These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea.
    Author: Sohn YM, Lee JS, Park JH, Poerschke G, Eves K, Gress J, Kuter B.
    Journal: Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):954-8. PubMed ID: 15916097.
    Abstract:
    We evaluated the CR326F strain (VAQTA) derived hepatitis A vaccine in Korean children and adolescents >2 years of age to consider a future immunization program. In our study, the pediatric two-dose regimen of VAQTA was found to be generally well tolerated and resulted in 100% (95% CI 94.8, 100.0) seroconversion after 2 doses. Immunizing children with the HAV vaccine routinely should be considered in South Korea, particularly in areas where recent outbreaks have occurred.
    [Abstract] [Full Text] [Related] [New Search]